Mathews Open Access Journals follow certain ethical standards to make sure high-quality scientific publications, to attain public confidence in scientific findings.
Plagiarism/ Duplicate Submission: Mathews Open Access Journals firmly encourages original manuscripts and must not use the words, figures, or ideas of others without attribution. All sources must be cited at the point they are used, and reuse of wording must be limited and be attributed or quoted in the text. The content should not be submitted/ published elsewhere with other publishing groups. Our quality control teams check for the plagiarism through software to detect the overlapping of content and similar text in submitted manuscripts. Manuscripts that are found to have been plagiarized from a manuscript by other authors, whether published or unpublished, will be rejected and the authors may incur sanctions. Any published articles may need to be corrected or retracted.
Data Fabrication and Falsification: If the submitted manuscripts are found to have either fabricated or falsified research work, i.e. methods, experimental results, including the manipulation of images will be immediately rejected.
Conflicts of Interest: Authors must declare all potential interests in a ‘Conflicts of interest’ section, which should explain why the interest may be a conflict. If there are none, the authors should state “The author(s) declare(s) that there are no conflicts of interest regarding the publication of this paper.” Submitting authors are responsible for coauthors declaring their interests.
Human and Animal Rights: Ethical clearance documents need to be provided if applicable. The work involving animal models and human volunteers need to submit the necessary statements.
In the above publication ethical cases if the violations are found, the editorial office is authorized to take action accordingly.
Published : 31st December 2020
Authors : Vincenzo De Simone*, Antonio Mugnolo, Alberto Zamboni, Giorgio Morando
Citation : De Simone V, et al. (2020). Myocardial infarction in Covid-19 era: a dramatic dip into the past?. Mathews J Cardiol. (5)1:22.
Published : 18th September 2019
Authors : Yutian Sun1, Hong Gao1, Boqi Hu2
Citation : Hu B. (2019). Multimodality Evaluation of Multiple Mitral Valve Myxomas: A Rare, Benign but Potentially Life-Threatening Tumor. Mathews J Cardiol 4(1): 21.
Published : 03rd March 2019
Author : Yasser Mohammed Hassanain Elsayed*
Citation : Elsayed YMH (2019). Test the Vasospastic ST-Segment Depression Reversibility with Nitrates in Non-Obstructive Coronary Disease. Mathews J Cardiol 4(1): 20.
Published : 15th November 2018
Authors : Osmar Antonio Centurión1,2*, FACC, FAHA, José Fernando Alderete1 , Judith María Torales1,2, Laura Beatriz García1,2, Karina Elizabeth Scavenius1
Citation : Centaurión OA, Alderete JF, Morales JM, Garcían LB, et al. (2018). Augmented Atrial Vulnerability in Patients with Sinus Node 3 Dysfunction: Is the Electrophysiologic Abnormality Limited Only to the Sinus Node?. Mathews J Cardiol. 3(1): 019.
Published : 14th November 2018
Authors : Luca Anfuso1 , Massimo Corsi1 , Antonio Fasano1,2
Citation : Anfuso L, Corsi M and Fasano A. (2018). Esophageal Thermal Probes: How Fast Should They Be?. Mathews J Cardiol. 3(1): 018.
Published : 25th September 2018
Authors : Osmar Antonio Centurión1,2, Christian O. Chávez-Alfonso1 , Laura Beatriz García1,2, Judith María Torales1,2
Citation : Centurión OA, Chávez-Alfonso C, García LB and Torales JM. (2018). Influence of Serum Biomarkers in the Diagnostic, Prog- 5 nostic and Therapeutic Management of Patients with Heart Failure Mathews J Cardiol. 3(1): 017..
Subscribe to our RSS feed, be in touch with our articles, news, videos, reebies.